PrPC-Apt DOA can be loaded with other drugs such as photosensitizers [62] and therapeutic nucleic acids [63] to develop co-delivery systems, which would show better therapeutic effects for Dox-resistant CRC. The gene discussed is PRNP; the disease is colorectal carcinoma.